Literature DB >> 28078570

Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1.

Chiara Fritegotto1,2, Chiara Ferrati1, Valentina Pegoraro2, Corrado Angelini3.   

Abstract

We aimed to explore the cellular action of micro-RNAs that are non-coding-RNAs modulating gene expression, whose expression is dysregulated in myotonic dystrophy (DM1). Basic procedure was to measure the levels of muscle-specific myo-miRNAs (miR-1, miR-133a/b, miR-206) in muscle of 12 DM1 patients. Muscle fiber morphometry and a new grading of histopathological severity score were used to compare specific myo-miRNA level and fiber atrophy. We found that the levels of miR-1 and miR-133a/b were significantly decreased, while miR-206 was significantly increased as compared to controls. The histopathological score did not significantly correlate with the levels of myo-miRNAs, even if the lowest levels of miRNA-1 and miRNA-133a/b, and the highest levels of miRNA-206 were observed in patients with either severe histopathological scores or long disease duration. The histopathological score was inversely correlated with disease duration. Nowadays that DM1 muscle biopsies are scanty, since patients are usually diagnosed by genetic analysis, our study offers a unique opportunity to present miRNA expression profiles in muscle and correlate them to muscle morphology in this rare multisystem disorder. Our molecular and morphologic data suggest a post-transcriptional regulatory action of myo-miRNA in DM1, highlighting their potential role as biomarkers of muscle plasticity.

Entities:  

Keywords:  Biomarkers; DM1; Micro-RNAs; Muscle; Myotonic dystrophy

Mesh:

Substances:

Year:  2017        PMID: 28078570     DOI: 10.1007/s10072-017-2811-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  20 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Bed rest reduces metabolic protein content and abolishes exercise-induced mRNA responses in human skeletal muscle.

Authors:  Stine Ringholm; Rasmus S Biensø; Kristian Kiilerich; Amelia Guadalupe-Grau; Niels Jacob Aachmann-Andersen; Bengt Saltin; Peter Plomgaard; Carsten Lundby; Jørgen F P Wojtaszewski; Jose A Calbet; Henriette Pilegaard
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-12       Impact factor: 4.310

Review 3.  MicroRNA-206: the skeletal muscle-specific myomiR.

Authors:  John J McCarthy
Journal:  Biochim Biophys Acta       Date:  2008-03-12

4.  Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy.

Authors:  Frédérique Rau; Fernande Freyermuth; Charlotte Fugier; Jean-Philippe Villemin; Marie-Christine Fischer; Bernard Jost; Doulaye Dembele; Geneviève Gourdon; Annie Nicole; Denis Duboc; Karim Wahbi; John W Day; Harutoshi Fujimura; Masanori P Takahashi; Didier Auboeuf; Natacha Dreumont; Denis Furling; Nicolas Charlet-Berguerand
Journal:  Nat Struct Mol Biol       Date:  2011-06-19       Impact factor: 15.369

5.  Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1.

Authors:  Riccardo Perbellini; Simona Greco; Gianluca Sarra-Ferraris; Rosanna Cardani; Maurizio C Capogrossi; Giovanni Meola; Fabio Martelli
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

Review 6.  MicroRNA in myogenesis and muscle atrophy.

Authors:  Xiaonan H Wang
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

7.  miRNAs as serum biomarkers for Duchenne muscular dystrophy.

Authors:  Davide Cacchiarelli; Ivano Legnini; Julie Martone; Valentina Cazzella; Adele D'Amico; Enrico Bertini; Irene Bozzoni
Journal:  EMBO Mol Med       Date:  2011-03-21       Impact factor: 12.137

8.  Muscle-specific microRNA miR-206 promotes muscle differentiation.

Authors:  Hak Kyun Kim; Yong Sun Lee; Umasundari Sivaprasad; Ankit Malhotra; Anindya Dutta
Journal:  J Cell Biol       Date:  2006-08-21       Impact factor: 10.539

9.  Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.

Authors:  Andrie Koutsoulidou; Tassos C Kyriakides; George K Papadimas; Yiolanda Christou; Evangelia Kararizou; Eleni Zamba Papanicolaou; Leonidas A Phylactou
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.

Authors:  Irina T Zaharieva; Mattia Calissano; Mariacristina Scoto; Mark Preston; Sebahattin Cirak; Lucy Feng; James Collins; Ryszard Kole; Michela Guglieri; Volker Straub; Kate Bushby; Alessandra Ferlini; Jennifer E Morgan; Francesco Muntoni
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more
  9 in total

1.  What Can be Learned from the Time Course of Changes in Low-Frequency Stimulated Muscle?

Authors:  Dirk Pette
Journal:  Eur J Transl Myol       Date:  2017-06-24

2.  Exciting perspectives for Translational Myology in the Abstracts of the 2018Spring PaduaMuscleDays: Giovanni Salviati Memorial - Chapter IV - Abstracts of March 17, 2018.

Authors:  Ugo Carraro
Journal:  Eur J Transl Myol       Date:  2018-02-20

Review 3.  Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy.

Authors:  Sandra O Braz; Julien Acquaire; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

4.  High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2.

Authors:  Marisa Cappella; Alessandra Perfetti; Beatrice Cardinali; Jose Manuel Garcia-Manteiga; Matteo Carrara; Claudia Provenzano; Paola Fuschi; Rosanna Cardani; Laura Valentina Renna; Giovanni Meola; Germana Falcone; Fabio Martelli
Journal:  Cell Death Dis       Date:  2018-06-28       Impact factor: 8.469

Review 5.  The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I.

Authors:  Emma Koehorst; Alfonsina Ballester-Lopez; Virginia Arechavala-Gomeza; Alicia Martínez-Piñeiro; Gisela Nogales-Gadea
Journal:  J Clin Med       Date:  2020-12-04       Impact factor: 4.241

Review 6.  Epigenetics of Myotonic Dystrophies: A Minireview.

Authors:  Virginia Veronica Visconti; Federica Centofanti; Simona Fittipaldi; Elisa Macrì; Giuseppe Novelli; Annalisa Botta
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 7.  Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies.

Authors:  Edyta Koscianska; Emilia Kozlowska; Agnieszka Fiszer
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 8.  MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy.

Authors:  Arturo López Castel; Sarah Joann Overby; Rubén Artero
Journal:  Int J Mol Sci       Date:  2019-11-09       Impact factor: 5.923

Review 9.  An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.

Authors:  Andrea López-Martínez; Patricia Soblechero-Martín; Laura de-la-Puente-Ovejero; Gisela Nogales-Gadea; Virginia Arechavala-Gomeza
Journal:  Genes (Basel)       Date:  2020-09-22       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.